-
Pharmacology
-
- Enzymes
-
- ATPase & GTPase
- Carboxylase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Hydroxylase
- Isomerase
- Kinase
-
- Adenosine kinase
- Akt
- AMP-kinase
- ATM
- CAM Kinase
- Casein kinase
- Cyclin-dependent kinase
- DNA-dependent Protein Kinase
- DYRK
- General
- Glycogen synthase kinase
- JAK
- MAPK
- mTOR
- Myosin light chain kinase
- PAK
- PI3-kinase
- PLK
- Protein Kinase A
- Protein Kinase C
- Protein Kinase G
- Rho kinase
- Sphingosine kinase
- Src
- Tyrosine Kinase
- Ligase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Orphan 7-TM Receptors
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- - Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 166 products in: Biochemicals >> Research Area >> Depression
Depression beginning with M - Z |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Group I /II metabotropic glutamate antagonist Purity: > 99% |   | ||
| Group I / II mGlu antagonist Purity: > 98% |  | ||
| Group I /II metabotropic glutamate antagonist; water soluble Purity: > 99% |  | ||
| NMDA antagonist, ion channel site Purity: > 98% | | ||
| Potent 5-HT receptor antagonist Purity: > 99% | | ||
| 5-HT agonist Purity: > 99% | | ||
| 5-HT receptor antagonist Purity: > 99% | | ||
| mGlu Agonists Kit |
| | |
| mGlu Antagonists Kit |
| | |
| Multiple receptor antagonist. Activity at 5-HT2, H1 and α2 receptors. Purity: > 99% | | ||
| Serotonin and norepinephrine reuptake inhibitor Purity: > 99% | | ||
| Antidepressant. α2, 5-HT2, 5-HT3 antagonist. Purity: > 99% | | ||
| Non-competitive NMDA antagonist Purity: > 99% | | ||
| Non competitive NMDA antagonist; less active enantiomer Purity: > 99% | | ||
| mGlu7 allosteric antagonist Purity: > 98% | | ||
| Potent, selective mGlu5 antagonist Purity: > 99% | | ||
| Potent, selective mGlu5 antagonist Purity: > 99% | | ||
| Fluorescent 5-HT1A antagonist Purity: > 97% | | ||
| Potent 5-HT1A antagonist Purity: > 99% | | ||
| AMPA / kainate antagonist Purity: > 98% | | ||
| AMPA / kainate antagonist; water soluble Purity: > 98% | | ||
| Potent 5-HT2A antagonist Purity: > 99% | | ||
| Control peptide for ( Purity: > 94% | | ||
| Competes with AP-2 binding to NR2B Purity: > 95% | | ||
| AMPA / kainate agonist Purity: > 98% | | ||
| Excitotoxic amino acid Purity: > 98% | | ||
| Non-selective 5-HT, dopamine, histamine and muscarinic antagonist. Purity: > 99% | | ||
| Selective 5HT3 antagonist. Purity: > 98% | | ||
| 5-HT uptake inhibitor Purity: > 99% | | ||
| Ionotropic receptor antagonist Purity: > 98% | | ||
| Inhibitor of AMPA receptor trafficking Purity: > 95% | | ||
| Selective allosteric potentiator at mGlu4. Also group I antagonist. Purity: > 98% | | ||
| 5HT3 receptor agonist Purity: > 99% | | ||
| GluA1/GluA2 (formerly GluR1/2) inhibitor Purity: > 98% | | ||
| 5-HT1A and 5-HT1B receptor antagonist Purity: > 99% | | ||
| GluN2C/GluN2D (formerly NR2C/NR2D) NMDA antagonist Purity: > 98% | | ||
| D2 and 5-HT2 antagonist. Antipsychotic. Purity: > 99% | | ||
| 5-HT receptor agonist Purity: > 99% | | ||
| Group I mGlu agonist. AMPA agonist. Purity: > 99% | | ||
| Neuroprotective agent. Modulates glutamate transmission. Purity: > 99% | | ||
| Atypical antipsychotic. 5-HT2A / D2 antagonist. Purity: > 99% | | ||
| NR2B antagonist Purity: > 98% | | ||
| Dopamine receptor agonist Purity: > 99% | | ||
| Selective, potent 5-HT2B antagonist Purity: > 99% | | ||
| Novel caged-glutamate compound, uncaged by visible light | | ||
| Selective 5-HT2B receptor antagonist Purity: > 99% | | ||
| Potent, selective 5-HT2B and 5-HT2C receptor agonist Purity: > 99% | | ||
| Selective h5-HT1B antagonist Purity: > 98% | | ||
| Potent, selective 5-HT7 receptor antagonist Purity: > 98% | | ||
| Potent, selective 5-HT6 antagonist Purity: > 99% | | ||
| Potent, selective 5HT6 antagonist Purity: > 99% | | ||
| Selective 5-HT5A receptor antagonist Purity: > 99% | | ||
| Endogenous NMDA receptor co-agonist Purity: > 98% | | ||
| Endogenous neurotransmitter, 5-HT receptor agonist Purity: > 99% | | ||
| Serotonin, noradrenaline & dopamine re-uptake inhibitor Purity: > 98% | | ||
| Endogenous polyamine. nNOS inhibitor. Purity: > 99% | | ||
| Endogenous polyamine Purity: > 99% | | ||
| 5-HT and D2-like receptor antagonist Purity: > 99% | | ||
| 5-HT1 receptor agonist Purity: > 99% | | ||
| 5-HT3 antagonist Purity: > 99% | | ||
| GluN2D (formerly NR2D) antagonist, with some subunit selectivity Purity: > 98% | | ||
| Potent, selective GluK1 (fomerly GLUK5) receptor antagonist Purity: > 98% | | ||
| Inactive isomer of the GluK1 (fomerly GLUK5) receptor antagonist UBP304 Purity: > 98% | | ||
| GluK1 and GluK3 selective antagonist Purity: > 98% | | ||
| Potent, selective EAAT1 inhibitor Purity: > 98% | | ||
| Serotonin-norepinephrine reuptake inhibitor Purity: > 99% | | ||
| PAM for mGluR4 Purity: > 99% | | ||
| PAM for mGluR4 (water soluble) Purity: > 99% | | ||
| Potent mGlu5 antagonist Purity: > 98% | | ||
| Potent, selective, silent 5-HT1A receptor antagonist Purity: > 98% | | ||
| AMPA / kainate receptor agonist Purity: > 98% | | ||
| mGlu1 antagonist Purity: > 98% | | ||
| Potent, selective mGlu1 antagonist Purity: > 99% | | ||
| Atypical antipsychotic. 5-HT2A / D2 antagonist. Purity: > 99% | | ||
| Fluorescent 5-HT1B antagonist Purity: > 97% | |